Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06027164 · ClinicalTrials.gov registry record
Kosmos Trio and Ejection Fraction Pivotal Study
A clinical trial of Cardiac Disease, sponsored by EchoNous.
- Completed
- Registry status
- 153
- Enrollment target
- 1
- Study location
NCT06027164: Completed study of Cardiac Disease, sponsored by EchoNous.
NCT06027164 is a study of Cardiac Disease that has completed, run by EchoNous. The registered enrollment target is 153 participants, below the 816-participant average among 24 other Cardiac Disease trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06027164, a study of Cardiac Disease, has completed, sponsored by EchoNous.
- COMPLETED
- Registry status
- 153 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-group, observational study which will involve obtaining two echo scans of recruited patients. All recruited patients will undergo echo scans by both novice users (nurses) and experts (echo sonographers). Image quality between novices and experts as well as the ability to calculate LVEF from novice and expert scans and the quality of the LVEF calculated via KOSMOS-EF compared to LVEF calculations by expert cardiologists will occur in post-hoc Echo image analysis
Primary Outcome
A panel of cardiologists will access and determine via a majority vote if a study exam acquired by a nurses is of sufficient image quality to make a qualitative visual assessment of the Global Left Ventricular Function.
Conditions Studied
Interventions
- DEVICE Portable Ultrasound System
Study Locations (1)
Michigan
- Revival Research Institute LLC - Dearborn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2023-08-04 |
| Est. Completion | 2024-05-16 |
What the finished NCT06027164 record still lists
NCT06027164 is an observational study that tracks outcomes without assigning an intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 816-participant average among 24 other Cardiac Disease trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Cardiac Disease appearing as the primary indexed condition, and to 1 intervention - of which Portable Ultrasound System is the first listed.
NCT06027164 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06027164 about?
NCT06027164 is a clinical study titled "Kosmos Trio and Ejection Fraction Pivotal Study". This is a single-group, observational study which will involve obtaining two echo scans of recruited patients. All recruited patients will undergo echo scans by both novice users (nurses) and experts (echo sonographers). Image quality between novices and experts as well as the ability to calculate L...
What is the current status of trial NCT06027164?
This trial is currently completed. The enrollment target is 153 participants. The study started on 2023-08-04. Estimated completion is 2024-05-16.
What conditions does trial NCT06027164 study?
This clinical trial studies the following conditions: Cardiac Disease.
What interventions are being tested in trial NCT06027164?
The interventions under investigation include: Portable Ultrasound System (DEVICE).
Who is sponsoring clinical trial NCT06027164?
This trial is sponsored by EchoNous, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06027164 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06027164's enrollment target sits among peer trials
153 12th of 24 higher than 11 of 24 other Cardiac Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cardiac Performance System Data Collection Study - Minnesota
RECRUITING
-
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
RECRUITING
-
Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
RECRUITING
-
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI